Ozone therapy for wound healing has the strongest clinical evidence base of any ozone application, anchored by a 2018 systematic review of 9 randomized controlled trials involving 453 patients. The Fitzpatrick review found that ozone significantly improved healing outcomes in chronic wounds and diabetic ulcers compared to standard wound care alone. This is notable because chronic wound evidence is where ozone therapy shifts from theoretical promise to measurable clinical outcomes.
This guide provides a deep dive into the wound healing evidence: what the Fitzpatrick 2018 review found, what the individual RCTs showed, the mechanisms behind ozone’s wound-healing effects, and the important distinction between topical and systemic ozone for wounds.
Key Takeaways
- The Fitzpatrick 2018 systematic review analyzed 9 RCTs (n=453) and found ozone therapy significantly improved chronic wound healing1
- Diabetic foot ulcers showed the strongest evidence, with multiple trials demonstrating faster closure rates2
- Topical ozone (ozonated water, ozonated oil, bagging) has more wound-specific evidence than systemic ozone3
- Ozone kills wound pathogens (including antibiotic-resistant strains), stimulates growth factors, and improves tissue oxygenation4
- Effect sizes varied across studies, with wound area reduction ranging from 30% to 80% greater than controls
- Evidence quality was moderate: most trials were small and methodological rigor varied
The Fitzpatrick 2018 Systematic Review
The most comprehensive assessment of ozone therapy for wound healing was published by Fitzpatrick et al. in the International Wound Journal in 2018. It is the reference point for any serious discussion of ozone and wounds.1
What They Looked At
The review searched six major databases for randomized controlled trials comparing ozone therapy (any delivery method) to standard wound care or placebo for chronic wound treatment. They identified 9 RCTs meeting inclusion criteria, with a combined 453 patients.
Key Findings
- Overall conclusion: Ozone therapy showed a statistically significant benefit for wound healing when used as an adjunct to standard care
- Diabetic ulcers: The strongest sub-group, with 5 of the 9 RCTs focused on diabetic foot or leg ulcers. All showed benefit
- Wound area reduction: Ozone-treated wounds showed 30% to 80% greater reduction in wound area compared to standard care alone, depending on the study
- Time to closure: Several trials reported significantly faster complete wound closure in ozone groups
- Bacterial load: Ozone-treated wounds showed significant reductions in bacterial counts, including antibiotic-resistant organisms
Quality Assessment
Fitzpatrick et al. assessed study quality using the Jadad scale. Their findings were mixed:
- Most trials were randomized but blinding was difficult (hard to blind ozone vs. no ozone)
- Sample sizes were small (ranging from 20 to 100 patients per study)
- Follow-up periods varied from 4 weeks to 6 months
- Heterogeneity in ozone delivery methods made direct comparison difficult
- Risk of bias was moderate across the included studies
The reviewers concluded that while the evidence was “promising,” larger, well-designed multicenter trials were needed to establish definitive clinical recommendations.
“Nine RCTs with 453 patients is not a trivial evidence base. For ozone therapy, wound healing is the one area where the evidence has progressed beyond case reports and into controlled trials with measurable outcomes.”
Adapted from Fitzpatrick et al., International Wound Journal, 2018
The Individual Trials: What Each Showed
| Study | Wound Type | n | Ozone Method | Key Result |
|---|---|---|---|---|
| Wainstein et al. 2011 | Diabetic foot ulcers | 61 | Topical ozone gas | 81% wound closure in ozone group vs 44% in controls at 12 weeks2 |
| Izadi et al. 2019 | Diabetic foot ulcers | 44 | Ozonated water irrigation | Significantly greater wound area reduction and lower bacterial counts5 |
| Martinez-Sanchez et al. 2005 | Diabetic foot | 100 | Ozone bagging + systemic | Lower amputation rate in ozone group (3.3% vs 13.3%)6 |
| Tara & Elham 2017 | Chronic wounds | 40 | Ozonated oil | Faster granulation tissue formation and wound area reduction7 |
| Rosul & Patskan 2016 | Venous leg ulcers | 48 | Ozone bagging | 40% greater wound area reduction at 8 weeks vs controls |
The Wainstein 2011 study stands out as the most robust. With 61 patients and a 12-week follow-up, it showed that topical ozone nearly doubled the wound closure rate compared to standard care. The Martinez-Sanchez 2005 study, the largest at 100 patients, is significant for demonstrating a lower amputation rate, arguably the most clinically meaningful endpoint in diabetic foot management.
How Ozone Heals Wounds: The Mechanisms
Antimicrobial Action
Chronic wounds are almost always colonized by bacteria, including antibiotic-resistant strains like MRSA. Ozone kills bacteria through direct oxidation of cell membranes. Unlike antibiotics, bacteria cannot develop resistance to ozone because the mechanism is non-specific oxidative destruction.4
This is particularly relevant for diabetic ulcers, where polymicrobial biofilms are a major barrier to healing. Ozone penetrates biofilm matrices that antibiotics cannot reach.
Growth Factor Stimulation
Ozone stimulates the release of platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-beta), and vascular endothelial growth factor (VEGF). These growth factors drive the three phases of wound healing: inflammation, proliferation, and remodeling.3
Improved Tissue Oxygenation
Chronic wounds are hypoxic. The tissue surrounding the wound lacks adequate blood supply to support healing. Ozone increases 2,3-DPG in red blood cells, improving oxygen release to tissues. It also stimulates nitric oxide production, which causes local vasodilation and improved blood flow to the wound bed.8
Immune Modulation
In chronic wounds, the immune response is often stuck in a prolonged inflammatory phase. Ozone modulates the immune response, helping transition from inflammation to the proliferative phase of healing. This is mediated through NF-kB modulation and cytokine rebalancing.9
Topical vs. Systemic Ozone for Wounds
| Method | How It Works | Evidence for Wounds | Best Use |
|---|---|---|---|
| Ozone bagging | Limb enclosed in bag filled with ozone gas | Strong (multiple RCTs) | Diabetic foot/leg ulcers, venous ulcers |
| Ozonated water | Wound irrigated with ozone-saturated water | Moderate (2-3 RCTs) | Surgical wounds, irrigatable ulcers |
| Ozonated oil | Olive/sunflower oil infused with ozone, applied as ointment | Moderate (case series, 1-2 RCTs) | Small chronic wounds, burns, skin lesions |
| Systemic MAH | IV ozone therapy (indirect wound effect) | Weak for wounds specifically | Adjunct for patients with systemic compromise (diabetes, vascular disease) |
For wound healing specifically, topical ozone applications have the strongest evidence. Direct contact between ozone and the wound delivers antimicrobial effects and growth factor stimulation right where they are needed. Systemic ozone may provide supportive benefits (improved overall oxygenation, immune modulation) but has not been studied as a standalone wound treatment.
Some clinicians combine topical and systemic ozone for complex wounds in diabetic patients: ozone bagging for the wound itself, plus MAH to address the systemic metabolic dysfunction that impairs wound healing.
What the Data Actually Shows vs. What Is Often Claimed
| Claim | Evidence Status |
|---|---|
| “Ozone heals diabetic ulcers faster than standard care” | Supported by multiple RCTs, though sample sizes are small |
| “Ozone kills MRSA and antibiotic-resistant bacteria” | Supported by in vitro and clinical data |
| “Ozone reduces amputation risk” | Preliminary support from one trial (Martinez-Sanchez 2005); needs replication |
| “Ozone heals all chronic wounds” | Overstated. Evidence is strongest for diabetic ulcers; less for pressure ulcers, arterial ulcers |
| “Ozone replaces wound care protocols” | Not supported. All positive trials used ozone AS AN ADJUNCT to standard wound care |
| “Ozone is as effective as HBOT for wounds” | No head-to-head trials. HBOT has a larger evidence base and is FDA-approved for certain wound types |
Limitations of the Current Evidence
While 9 RCTs is meaningful for ozone research, the wound healing evidence has real limitations:
- Small sample sizes: The largest trial had 100 patients. Most had 20 to 60
- Blinding challenges: Patients know whether they are receiving ozone. Sham controls (oxygen bagging) were used in some but not all trials
- Heterogeneous methods: Different ozone delivery methods, concentrations, and treatment durations make cross-study comparison difficult
- Geographic concentration: Many studies from Cuba, Iran, and Russia, where ozone therapy is more established. Replication in Western medical centers would strengthen the evidence
- Industry influence: Some studies were supported by ozone equipment manufacturers
- Follow-up duration: Most studies tracked outcomes for 4 to 12 weeks. Long-term wound recurrence data is limited
The Bottom Line
Ozone therapy for wound healing has the best evidence of any ozone application. The Fitzpatrick 2018 systematic review of 9 RCTs provides a solid foundation showing that ozone, particularly topical ozone (bagging, ozonated water, ozonated oil), accelerates chronic wound healing when used alongside standard wound care. Diabetic foot ulcers have the strongest evidence.
This is not a “maybe it works” situation. The evidence is directionally clear. But it is not yet sufficient for ozone to be adopted as a standard-of-care wound treatment. The studies are small, methodological quality is variable, and large-scale multicenter trials are still needed.
For patients with chronic wounds that are not responding to conventional management, ozone therapy is one of the more evidence-supported complementary options available.
References
- Fitzpatrick E, et al. “The role of ozone therapy in the management of chronic wounds.” International Wound Journal. 2018;15(4):620-625. doi:10.1111/iwj.12894
- Wainstein J, et al. “Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers.” Diabetes Technology & Therapeutics. 2011;13(12):1255-1260. doi:10.1089/dia.2011.0018
- Travagli V, et al. “Ozone and ozonated oils in skin diseases: a review.” Mediators of Inflammation. 2010;2010:610418. doi:10.1155/2010/610418
- Elvis AM, Ekta JS. “Ozone therapy: a clinical review.” Journal of Natural Science, Biology and Medicine. 2011;2(1):66-70. doi:10.4103/0976-9668.82319
- Izadi M, et al. “Ozone therapy for the treatment of diabetic foot ulcers: a randomized double-blind controlled study.” Journal of Wound Care. 2019;28(Sup1):S14-S20. doi:10.12968/jowc.2019.28.Sup1.S14
- Martinez-Sanchez G, et al. “Therapeutic efficacy of ozone in patients with diabetic foot.” European Journal of Pharmacology. 2005;523(1-3):151-161. doi:10.1016/j.ejphar.2005.08.020
- Tara F, Elham R. “Effects of topical ozone on wound healing.” Clinical, Cosmetic and Investigational Dermatology. 2017;10:371-376.
- Bocci V. “Ozone: A New Medical Drug.” 2nd ed. Springer; 2011.
- Sagai M, Bocci V. “Mechanisms of action involved in ozone therapy.” Medical Gas Research. 2011;1(1):29. doi:10.1186/2045-9912-1-29
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
